よむ、つかう、まなぶ。

MC plus(エムシープラス)は、診療報酬・介護報酬改定関連のニュース、

資料、研修などをパッケージした総合メディアです。


【参考資料2】薬剤耐性ワンヘルス動向調査報告書2021 (103 ページ)

公開元URL https://www.mhlw.go.jp/stf/newpage_29073.html
出典情報 薬剤耐性ワンヘルス動向調査検討会(第10回 11/21)《厚生労働省》
低解像度画像をダウンロード

資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。

引用文献
1.

Hashimoto H, Matsui H, Sasabuchi Y, Yasunaga H, Kotani K, Nagai R, et al. Antibiotic prescription among outpatients in a
prefecture of Japan, 2012–2013: a retrospective claims database study. BMJ Open [Internet]. 2019 Apr 3

2.

Higashi T, Fukuhara S. Antibiotic prescriptions for upper respiratory tract infection in Japan. Intern Med. 2009;48:1369–75.

3.

Yoshida S, Takeuchi M, Kawakami K. Prescription of antibiotics to pre-school children from 2005 to 2014 in Japan: a
retrospective claims database study. J Public Health (Oxf). 2018;40:397–403.

4.

Teratani Y, Hagiya H, Koyama T, Adachi M, Ohshima A, Zamami Y, et al. Pattern of antibiotic prescriptions for outpatients with
acute respiratory tract infections in Japan, 2013–15: a retrospective observational study. Fam Pract. 2019;36:402–9.

5.

Kimura Y, Fukuda H, Hayakawa K, Ide S, Ota M, et al.. Longitudinal trends of and factors associated with inappropriate
antibiotic prescribing for non-bacterial acute respiratory tract infection in Japan: A retrospective claims database study, 20122017. PLoS One. 2019; 14(10):e0223835.

6.

Tomii K, Matsumura Y, Maeda K, Kobayashi Y, Takano Y, Tasaka Y. Minimal use of antibiotics for acute respiratory tract
infections: validity and patient satisfaction. Intern Med. 2007;46:267–72.

7.

Okubo Y, Michihata N, Morisaki N, Kinoshita N, Miyairi I, Urayama KY, et al. Recent patterns in antibiotic use for children with
group A streptococcal infections in Japan. J Glob Antimicrob Resist. 2018 Jun;13:55–9.

8.

Okubo Y, Miyairi I, Michihata N, Morisaki N, Kinoshita N, Urayama KY, et al. Recent Prescription Patterns for Children With
Acute Infectious Diarrhea. J Pediatr Gastroenterol Nutr. 2019;68:13–6.

9.

Karen E. Jerardi and Elizabeth C. Jackson. Nelson Textbook of Pediatrics, Chapter 553, 2789-2795.e1 田中宏明ら.“水環境の医薬
品類汚染とその削減技術の開発” 環境技術 Vol.37 No. 12., 2008.

10.

Park J, et al. “Removal characteristics of PPCPs: comparison between membrane bioreactor and various biological treatment
process.” Chemosphere. 2017; 179: 347e358.

11.

Narumiya M, et al. “Phase distribution and removal of PPCPs during anaerobic sludge digestion” Journal of Hazardous
Materials 2013; 260: 305 - 312.

12. Azuma T, et al. “Evaluation of concentrations of pharmaceuticals detected in sewage influents in Japan by using annual
shipping and sales data” Chemosphere. 2015;138 :770 -776.
13.

World Organization for Animal Health (OIE), "Monitoring of the Quantities and Usage patterns of Antimicrobial Agents Used
in Food-Producing Animal"
http://www.oie.int/fileadmin/Home/eng/Health_standards/tahc/current/chapitre_antibio_monitoring.pdf

14. 2019 年度(令和元年度) 化学物質環境実態調査 調査結果報告書
http://www.env.go.jp/chemi/kurohon/2020/index.html
15. 「令和2年度化学物質環境実態調査結果(概要)」について
https://www.env.go.jp/press/110366.html

102